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Objective: Phthalates and their metabolites are classiﬁed as endocrine modulators. They affect the hor-
monal balance in both children and adults.
The aim of this publication was to compare the urinary levels of phthalate metabolites in selected
populations of the Czech Republic (CZ), Slovakia (SK), and Hungary (HU) in relation to the sources of
phthalate exposure identiﬁed by means of questionnaire (personal care products, ﬂoor and wall cover-
ings, plastic toys, and some kinds of foods).
Methods: Data were obtained through the twin projects COPHES (COnsortium to Perform Human biomoni-
toring on a European Scale) and DEMOCOPHES (DEMOnstration of a study to COordinate and Perform Human
biomonitoring on a European Scale) from 2009 to 2012. The target groups were children aged 6–11 years old
and their mothers up to 45 years of age. The metabolites of phthalates (monomethyl phthalate (MMP),
monoethyl phthalate (MEP), monobenzyl phthalate (MBzP), mono-cyclohexyl phthalate (MCHP), mono-(2-
ethylhexyl) phthalate (MEHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP), and mono-(2-ethyl-5-
oxohexyl) phthalate (5OXO-MEHP)) were analysed in ﬁrst morning urine samples. After enzymatic glucuronide
cleavage, the urine sample analyses were performed using ultra-high-performance liquid chromatography–
electrospray ionization tandem mass spectrometry (UHPLC–ESI-MS/MS) in one laboratory that qualiﬁed in the
External Quality Assessment exercises organised by COPHES.
Results: Signiﬁcant differences in phthalate exposure between countries were revealed for children only but
not for mothers. The concentrations of 5-OH-MEHP (Po0.001), 5OXO-MEHP (Po0.001), and their sum
(Po0.001) were the highest in SK compared to CZ and HU. The health based guidance values for the sum ofblic Health, Šrobárova 48, Prague 10 100 42, Czech Republic.
l., Case study: Possible differences in phthalates exposure among the Czech, Hungarian, and
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Slovak populations identiﬁed.... Environ.DEHP metabolites 5-OH MEHP and 5OXO-MEHP established by the German Commission for biomonitoring of
300 mg/L and 500 mg/L for women adults and children, respectively, were only exceeded in one mother and
three boys. A signiﬁcant difference was also found for MEP (P¼0.0149), with the highest concentrations de-
tected in HU. In all countries, the increasing frequency of using personal care products signiﬁcantly elevated the
concentrations of MEP.
Conclusion: Some differences were observed between countries in the concentrations of individual urinary
phthalate metabolites in children. However, the questionnaire results give no direct explanation for the dif-
ferences between the countries except the variation in using personal care products.
& 2014 Elsevier Inc. All rights reserved.1. Introduction
Human biomonitoring (HBM) is a tool for evaluating popula-
tion exposure to potentially critical chemicals found in the en-
vironment, contaminated foodstuffs, lifestyle, use of different
products, and other sources. This approach allows characterising
the body burden from all exposure sources and has been in-
creasingly applied in environmental health surveys in the last
decade all over the world (Angerer et al., 2007; Needham et al.,
2007).
Although HBM has been practiced for several years in several
European countries (Becker et al., 2002, 2003; Černá et al., 2007;
Fréry et al., 2012; Cañas, et al., 2014; Schindler et al., 2014), Europe
as such—unlike the USA (CDC, 2013)—has no comparable data on
the levels of environmental chemicals in the body for their po-
pulation. Results produced by individual European countries are
not always comparable as the studies may differ in the metho-
dological steps like recruitment of body ﬂuid donors, choice of
population groups, selection of biomarkers and analytical
procedures.
Therefore, the European Environment and Health Action Plan
2004 prioritized the need to harmonise HBM in Europe to be able
to obtain internationally comparable data (EHAP, 2004; Joas et al.,
2012). Uniﬁed protocols developed by the COPHES project (COn-
sortium to Perform Human biomonitoring on a European Scale)
and the practical use of these Standard operational procedures
(SOPs) in the DEMOCOPHES project (DEMOnstration of a study to
COordinate and Perform Human biomonitoring on a European
Scale) allowed to produce comparable data by means of harmo-
nized methodological procedures within the DEMOCOPHES pilot
study (Becker et al., 2014; Schindler et al., 2014).
For the DEMOCOPHES pilot study, children aged between 6 and
11 years old were chosen as the main target group. The reason
being that children belong to the most vulnerable population
group, and that the protection of children's health is a main
priority for the environmental health policy. The exposure of in-
fants and children to environmental toxic compounds early on in
life may adversely inﬂuence their quality of life in later periods
(Au, 2002). Additionally, the children's mothers were included.
The population group of mothers as women of reproductive age is
another known vulnerable group with similar lifestyle character-
istics and habits to the children under study.
Several environmental pollutants with known biomarkers of
exposure (cadmium and cotinine in urine and mercury in hair)
were selected for the DEMOCOPHES pilot study based on ongoing
knowledge of HBM requirements taking into account the demands
of participating countries discussed in the Consultative Forum in
the frame of the EU Environment and Health Action Plan (Becker
et al., 2014; Joas et al., 2012). Contrary to the existing HBM sce-
narios in which generally the population exposure to traditional
environmental pollutants covered by sufﬁcient analytical experi-
ence like heavy metals or persistent organic pollutants is mon-
itored, this pilot study also included phthalates. They represent a
relatively new group of emerging types of environmentall., Case study: Possible diffe
Res. (2014), http://dx.doi.orgcontaminants, identiﬁed due to increasing public and political
awareness (Zimmer et al., 2012), which started to be included into
the spectrum of monitored biomarkers only in the last decade
(Barr et al., 2003; Koch et al., 2003a).
Some phthalates such as di(2-ethylhexyl) phthalate (DEHP) have
been widely used as plasticizers in numerous products (Lyche et al.,
2009). Other phthalate derivatives are also used for different purposes
dependent on their molecular weight, e.g. as additives in the textile
industry (DEHP, di-isononyl phthalate (DiNP), and di-isodecyl
phthalate (DiDP), etc.), personal care products (dimethyl phthalate
(DMP), diethyl phthalate (DEP), di-n-butyl phthalate (DBP), etc.),
paints and construction materials (DiNP, DiDP) or adhesives (ATSDR,
2002; Heudorf et al., 2007). At present, the US general population is
exposed to phthalates to quite a large extent (Hauser and Calafat,
2005). As phthalates are classiﬁed as endocrine disruptors and re-
productive toxicants, the exposure of children is of particular concern
(Swan et al., 2005). Phthalates enter the human body by ingestion,
inhalation and dermal absorption (Wittassek et al., 2011). They are
quickly metabolised in the organism and metabolites are excreted in
urine (Koch et al., 2006). Urinary metabolites of phthalates are con-
sidered relevant indicators of phthalate exposure (Koch et al., 2003b,
2006). Therefore metabolites were included in the range of bio-
markers monitored in the DEMOCOPHES pilot study. At the beginning
of this study, only very few laboratories were able to analyse the most
important metabolites of phthalates so as to match Interlaboratory
Comparison Investigation/External Quality Assessment Scheme (ICI/
EQUAS) tests (Schindler et al., 2014). The laboratory of the National
Institute of Public Health (NIPH) in Prague was one of the few which
succeeded in the ICI/ EQUAS exercise). Therefore, the analyses of se-
lected phthalate metabolites in the samples from the Czech Republic,
Slovakia and Hungary were performed in the NIPH laboratory.
Data regarding the concentration of urinary phthalate meta-
bolites obtained in the Democophes study for all 17 participating
European countries have shown marked differences and the
highest mean urinary DEPH metabolite concentrations were found
in children from Slovakia (Den Hond et al., unpublished data).
Therefore the main objective of this manuscript was to try to
identify the possible causes of this ﬁnding taking into account
responses obtained in basal questionnaire (Fiddicke et al., this is-
sue) and explain higher concentrations of urinary phthalate me-
tabolites in Slovak children compared with neighbouring states.2. Materials and methods
2.1. Sampling and questionnaire
In the Czech Republic and Hungary, 120 pairs of children aged
6 to 11 years old and their mothers from urban and rural areas
each were examined while in Slovakia 129 such pairs were en-
rolled. In all three countries study subjects were recruited through
schools, equally in urban and rural areas as deﬁned according to
regional standards. Generally samples and sampling were notrences in phthalates exposure among the Czech, Hungarian, and
/10.1016/j.envres.2014.10.025i
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the feasibility of using a uniﬁed protocol all over Europe was in the
focus of COPHES and DEMOCOPHES. Information on study popu-
lation characteristics and potential determinants of exposure were
obtained through personalized interviews (Table 1). Trained ﬁeld
workers visited families in their homes at times that would suit
the families to collect paired maternal and child morning urine
and hair samples in accordance with COPHES SOPs and to carry
out the questionnaire directly with the mothers.
Basic questionnaire (BQ) was developed concerning exposure
pathways for the biomarkers included to the study (Fiddicke et al.,
this issue). Questions regarding potential exposure to phthalates
concerned household equipment (e.g. PVC ﬂoor, renovation of ﬂat
or house, nutrition (namely convenience or fast food, ice cream,
local food etc.), use of personal care products, use of plastic gloves,
and playing with plastic toys (children). Other lifestyle factors likeTable 1
Descriptive statistics of mothers and children enrolled in the study.
Mothers Children
CZ HU SK CZ HU SK
collected samples 120 120 129 120 120 129
N—analysed
samples
117 115 125 120 117 127
Mean age (range) 37.5
(29–45)
36.4
(26–45)
37.0
(24–46)
8.4
(6–11)
8.5
(6–11)
8.4
(6–11)
Creatinine [mg/L]
o300a 3 3 2 0 2 0
300–3000 117 115 125 120 117 127
43000a 0 2 2 0 1 2
Age group
o¼35 years 37 47 45 – – –
35–40 years 56 45 51 – – –
440 years 24 23 29 – – –
6–8 year – – – 61 59 66
9–11 years – – – 59 58 61
Gender
Boys – – – 59 59 66
Girls – – – 61 58 61
Smoking status
Daily smoker 13 29 15 – – –
Occasional smoker 11 8 8 – – –
Ex-smoker 18 18 21 – – –
Never smoker 78 65 85 – – –
Education
Primary (ISCED 0–2) 1 1 1 – – –
Secondary (ISCED 3–
4)
65 72 68 – – –
Tertiary (ISCED 5–6) 54 46 60 – – –
Highest education in family
Primary (ISCED 0–2) 3 4 0 – – –
Secondary (ISCED 3–
4)
51 63 55 – – –
Tertiary (ISCED 5–6) 66 52 74 – – –
Alcohol consumptionb
Mean (range) 2.4 (0–
17)
0.8 (0–
14)
1.0 (0–
8)
– – –
ISCED-International Standard Classiﬁcation of Education.
a Excluded from study.
b According to DEMOCOPHES, in units per week.
Please cite this article as: Černá, M., et al., Case study: Possible diffe
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also followed.
The study was approved by the Ethical Committees in each of
the participating countries and all mothers recruited gave in-
formed written consent to participate in the study.
2.2. Determination of phthalate metabolites
Biomarkers in DEMOCOPHES samples could be analysed by labs
that were successful in at least one ICI and one EQUAS exercise or
two EQUAS exercises. The laboratory that actually carried out the
analyses successfully qualiﬁed in the External Quality Assessment
exercises organised by COPHES (Schindler et al., 2014).
According to the requirements of the COPHES/DEMOCOPHES
coordination team, nine phthalate metabolites, as listed in Table 2,
and their labelled analogues (D or 13C) were purchased from
Sigma-Aldrich, Dr. Ehrenstorfer, and Cambridge Isotope Labora-
tories or were a generous gift from Professor Jürgen Angerer
(University of Erlangen, Nuremberg, Germany); β-glucuronidase
was purchased from Roche.
Human urine samples were collected in glass vials and stored
at 18 °C prior to analysis. Half millilitre of urine sample was
processed using published procedures (Blount et al., 2000; Koch
et al., 2003b) with enzymatic cleavage of glucuronide. For the
calibration, water solutions with concentrations from 0.5 to
200 μg/L were prepared. The internal standards were added to all
calibration solutions and the samples. In this study, we took ad-
vantage of the available instrumentation and therefore, the sam-
ples after incubation with β-glucuronidase were not concentrated,
but only diluted with a mobile phase and injected (20 μL), which
led to satisfactory limits of detection (LODs).
The analyses were performed using ultra-high-performance
liquid chromatography electrospray ionization triple quadrupole
tandem mass spectrometry (UHPLC–ESI-MS/MS) (Agilent Tech-
nologies). The ion source was Jet Stream ESI. The chromatograph
was equipped with an analytical column (Poroshell 120 SB-C18,
2.7 μm, 1503 mm). The mobile phase gradient consisted of 1%
acetic acid and acetonitrile. Another chromatographic column,
Zorbax Eclipse Plus C18 Rapid Resolution HD, 1.8 μm, 502.1 mm,
was inserted between the binary pump and autosampler and was
used as a trap to capture interferences from the mobile phase, and
to delay them as compared with the metabolites from injection.Table 2
Phthalate metabolites analysed in urine samples from the CZ, HU, and SK within
the DEMOCOPHES pilot study.
Parental
phthalate
Metabolites Acronyms Note
DMP Monomethyl phthalate MMP More than 50%
below LOQ
DEP Monoethyl phthalate MEP
DBP Mono-n-butyl phthalate MnBP n
BzBP Monobenzyl phthalate MBzP
Mono-n-butyl phthalate MnBP n
DCHP Monocyclohexyl phthalate MCHP More than 90%
below LOQ
DEHP Mono(2-ethylhexyl)
phthalate
MEHP
Mono(2-ethyl-5-hydro-
xyhexyl) phthalate
5OH-MEHP
Mono(2-ethyl-5-oxohexyl)
phthalate
5OXO-MEHP
nBoth metabolites MnBP and MiBP were measured, but are not listed due to doubts
about their proper resolution. In fact, MnBP results were successfully evaluated in
the frame of EQUAS organized by COPHES, but the data on MiBP were not sent to
EQUAS for evaluation.
rences in phthalates exposure among the Czech, Hungarian, and
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Table 3
Performance parameters of analytical method.
Parameter MMP MEP MnBP MBzP MCHP MEHP 5OH-
MEHP
5OXO-
MEHP
LOD [mg/L] 0.09 0.2 0.5 0.4 0.07 0.7 0.2 0.08
LOQ [mg/L] 0.27 0.6 1.5 1.2 0.2 2.0 0.6 0.24
r2 [%] 12 9 9 7 7 4 5 5
r20 [%] 6 4 4 5 4 2 3 3
r150 [%] 5 3 4 6 6 2 4 7
R2 [%] 110 82 110 97 87 73 105 94
R20 [%] 99 93 87 103 91 90 105 97
R150 [%] 102 95 90 103 94 96 106 100
M. Černá et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎4The quality of the measurements was checked not only in ICI/
EQUAS, but also blanks and quality control samples were added to
every round of measurements.
The performance characteristics according to the requests from
the COPHES project were assessed (see results in Table 3): limits of
detection (LOD) and quantiﬁcation (LOQ), repeatability (r) ex-
pressed as relative standard deviation (RSD) at three concentration
levels. No reference materials were available, so the exactitude had
to be assessed as recovery (R). The results are adequate for testing
DEMOCOPHES samples.
The creatinine analysis was provided by the accredited la-
boratory using an already published method (Schneiderka et al.,
1993). This laboratory also achieved good results in EQUAS. The
sample diluted with water was analysed by liquid chromatography
coupled to a diode array detector (HPLC-DAD).
Urinary biomarkers are expressed either as a concentration
(μg/L) or as a creatinine-corrected value (μg/g of creatinine).
2.3. Statistical analysis
Analysed data were derived from the COPHES/DEMOCOPHES
European central database. Samples with creatinine concentra-
tions below 300 mg/L or above 3000 mg/L (WHO, 1996) were ex-
cluded from statistical analyses (Table 1). Phthalate metabolite
concentrations below the LOQ were replaced with 1/2 LOQs.Table 4
Values of the urinary phthalate metabolites [mg/L] for mothers and their children in the
conﬁdence interval.
CZ SK
Mothers (N¼117) Children (N¼120) Mothe
MEHP 3.33 (2.87; 3.87) 3.80 (2.65; 3.59) 3.96 (3
%oLOQ 23.9 27.5 20.0
5OH-MEHP 19.62 (17.16; 22.42) 36.98 (32.52; 42.05) 22.40
%oLOQ 0 0 0
5OXO-MEHP 12.42 (10.93; 14.11) 24.77 (21.73; 28.24) 14.21 (
%oLOQ 0 0 0
MEP 56.66 (43.68; 73.48) 31.60 (26.27; 38.01) 54.81
%oLOQ 0 0 0
MBzP 4.62 (3.68; 5.81) 8.32 (6.89; 10.40) 4.70 (4
%oLOQ 9.4 0 4.8
∑ of the metabolites of DEHPa 32.16 (28.22; 36.64) 61.88 (54.39; 70.41) 36.72
%oLOQ 0 0 0
MCHP
%oLOQ 98.3 89.2 98.4
MMP
%oLOQ 80.3 58.3 90.4
Note: CZ—Czech Republic, SK—Slovakia, HU—Hungary; N—number of subjects; %oLOQ—
a ∑ of the metabolites of DEHP¼5OXO-MEHPþ5OH-MEHP.
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95% conﬁdence intervals. Between-group comparisons were based
on various models of analysis of variance and covariance applied
to the natural logarithm-transformed data. In case of signiﬁcant
results, Sidak's multiple comparison procedure was used to de-
termine which pairs of groups differ. Unadjusted and adjusted
comparisons among countries were done. Covariates included in
the models were age, gender (children only), industry with pos-
sible contamination of phthalates in neighbourhood of residence,
vinyl ﬂooring, main source of drinking water, milk consumption,
use of personal care products (mothers only), and use of shampoo
(children only). For urinary biomarkers expressed as a con-
centration (μg/L) the extension by creatinine used as a covariate
was also considered.
Associations between mothers and children were quantiﬁed by
the Spearman correlation coefﬁcients. The inter-country differ-
ences in the relationship between the values of mothers and
children were tested using the interaction term in a model where
the maternal values and country were independent variables, and
the child's values the dependent variable. For categorical data, the
differences in proportions among the groups were analysed using
Fisher's exact test. All statistical tests were evaluated as two-sided
at a signiﬁcance level of 0.05. Statistical analysis was performed by
the statistical software Stata, release 9.2 (Stata Corp LP, College
Station, TX).3. Results and discussion
3.1. BASIC characteristics of the children and mothers
Descriptive statistics of the children and mothers from CZ, HU
and SK included in the study are presented in Table 1. According to
the European study protocol, study subjects were equally recruited
by the predeﬁned strata of gender, age, and sampling area in each
country. Therefore, the three countries did not differ in the gender
distribution of children or in the age distribution of mothers and
children.three countries studied. Data in bold and in brackets are geometric mean and 95%
HU
rs (N¼125) Children (N¼127) Mothers (N¼115) Children (N¼117)
.38; 4.64) 3.95 (3.35; 4.65) 3.83 (3.18; 4.61) 3.65 (3.6; 4.35)
22.1 25.2 24.8
(19.66; 25.53) 49.30 (43.39; 56.00) 19.37 (16.47; 22.79) 33.65 (28.94; 39.11)
0 0 0
12.49; 16.17) 33.26 (29.23; 37.86) 12.93 (11.00; 15.20) 22.91 (19.71; 26.63)
0 0 0
(44.15; 68;04) 39.64 (33.39; 47.06) 55.04 (44.17; 68.58) 46.98 (38.25; 57.70)
0 0 0
.10; 5.50) 8.35 (7.10; 9.82) 4.76 (4.20; 5.65) 7.57 (6.21; 9.23)
0.8 5.2 0.9
(32.26; 41.79) 82.75 (72.83; 94.02) 32.40 (27.56; 38.08) 56.70 (48.80; 65.89)
0 0 0
98.4 98.3 99.2
70.1 67.8 53.0
the percentage of values below the quantiﬁcation limit of the method.
rences in phthalates exposure among the Czech, Hungarian, and
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Table 5
Values of the urinary phthalate metabolites [mg/g creatinine] for mothers and their children in the three countries studied. Data in bold and in brackets are geometric mean
and 95% conﬁdence interval.
CZ SK HU
Mothers (N¼117) Children (N¼120) Mothers (N¼125) Children (N¼127) Mothers (N¼115) Children (N¼117)
MEHP 3.13 (2.70; 3.65) 3.14 (2.71; 3.64) 3.22 (2.80; 3.69) 3.26 (2.28; 3.77) 3.70 (2.60; 3.62) 3.23 (2.78; 3.75)
%oLOQ 23.9 27.5 20.0 22.1 25.2 24.8
5OH-MEHP 18.45 (16.40; 20.75) 37.69 (33.97; 41.48) 18.20 (16.45; 20.14) 40.69 (36.55; 54.31) 15.54 (13.67; 17.67) 29.77 (26.29; 33.70)
%oLOQ 0 0 0 0 0 0
5OXO-MEHP 11.68 (10.41; 13.10) 25.25 (22.71; 28.70) 11.54 (10.45; 12.75) 27.46 (24.57; 30.69) 10.37 (9.15; 11.74) 20.27 (17.86; 22.99)
%oLOQ 0 0 0 0 0 0
MEP 53.28 (42.03; 67.55) 32.20 (27.28; 38.02) 44.53 (36.41; 54.46) 32.72 (28.40; 38.18) 44.15 (35.97; 54.19) 41.56 (34.15; 50.58)
%oLOQ 0 0 0 0 0 0
MBzP 4.35 (3,58; 5.29) 8.48 (7.18; 10.10) 3.81 (3.32; 4.39) 6.89 (5.96; 7.97) 3.82 (3.31; 4.40) 6.70 (5.54; 8.90)
%oLOQ 9.4 0 4.8 0.8 5.2 0.9
∑ of the metabolites of DEHPa 30.24 (26.95; 33.94) 63.07 (56.85; 69.98) 29.83 (26.99; 32.97) 68.31 (61.30; 76.13) 25.99 (22.91; 29.48) 50.16 (44.29; 56.82)
%oLOQ 0 0 0 0 0 0
MCHP
%oLOQ 98.3 89.2 98.4 98.4 98.3 99.2
MMP
%oLOQ 80.3 58.3 90.4 70.1 67.8 53.0
Note: CZ—Czech Republic, SK—Slovakia, HU—Hungary; N—number of subjects; %oLOQ—the percentage of values below the quantiﬁcation limit of the method.
a ∑ of the metabolites of DEHP¼5OXO-MEHPþ5OH-MEHP.
M. Černá et al. / Environmental Research ∎ (∎∎∎∎) ∎∎∎–∎∎∎ 53.2. Distribution of phthalate metabolites and differences among
countries
The concentrations of urinary phthalate metabolites are ex-
pressed in mg/L urine (Table 4) and as the creatinine-corrected
concentrations (mg/g creatinine) (Table 5).
Statistical signiﬁcant differences in the volumetric concentra-
tions (mg/L) of the metabolites 5-OH MEHP (Po0.001), 5OXO-
MEHP (Po0.001), and sum of both (Po0.001) were found only
among children from the three countries, with a downwardFig. 1. Box and Whisker plots expressing phthalate metabolite concentrations
Please cite this article as: Černá, M., et al., Case study: Possible diffe
Slovak populations identiﬁed.... Environ. Res. (2014), http://dx.doi.org/sequence of SK4CZ4HU. Further statistical signiﬁcant differ-
ences among children from the three countries were found for
MEP with the highest concentration in HU (P¼0.015). (Fig. 1).
Weaker but still signiﬁcant differences for the same metabo-
lites (5-OH MEHP, P¼0.034, 5OXO-MEHP, P¼0.051), sum of both
(P¼0.039) and MEP (P¼0.032) were found when creatinine was
used as one of the covariates together with others (gender, vinyl
ﬂooring, industry with possible contamination of phthalates in
neighbourhood of residence, milk consumption, main sources of
drinking water, and use of personal care products). No differences(μg/L) in children from countries under investigation (logarithmic scale).
rences in phthalates exposure among the Czech, Hungarian, and
10.1016/j.envres.2014.10.025i
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countries either in unadjusted or in creatinine adjusted analyses.
However, the levels of creatinine in children and mothers differ
among the countries with a sequence CZoHUESK (P¼0.005).
3.3. Gender-related differences in children
Gender-related differences in the concentrations of phthalate
metabolites were analysed separately for each country. In CZ boys
had signiﬁcantly higher concentrations of MEP (P¼0.002) and
MBzP (P¼0.025) than girls. In HU boys had signiﬁcantly higher
concentrations of MEHP (P¼0.009). No signiﬁcant gender-related
differences were observed in children from SK.
3.4. Lifestyle
No differences among the three countries were observed in the
consumption of hazelnut spread, convenience food, cereals, cho-
colate, local food, or other food items supposed to inﬂuence
phthalate exposure (Heinemeyer et al., 2013). Other potential
confounding factors such as smoking rate, alcohol consumption,
and dietary habits could not explain any observed effects.
In this study, signiﬁcant differences among mothers from the
three countries were observed in the frequency of using make-up
(Po0.001), shampoo (Po0.001), hair styling products (Po0.001),
body lotions and creams (Po0.001). On the other hand, no dif-
ferences were found in using eye make-up, fragrances, deodorants,
massage oils, or nail polish. In children, signiﬁcant differences
were observed in the frequency of using shampoo (Po0.001),
which was lowest in HU. Slovak children used more frequently
body lotions and creams (P¼0.012) than their peers in CZ or HU.
The parent compound DEP is commonly used in personal care
products (Koniecki et al., 2011). Indeed, in each country, the fre-
quency of using personal care products was signiﬁcantly asso-
ciated with the concentrations of MEP but more strongly in mo-
thers (Po0.001) than in children (P¼0.023). However, signiﬁcant
differences among countries in the MEP concentrations are only
observed for children. Therefore the questions whether this single
factor might explain the signiﬁcantly higher levels of urinary
metabolites in Slovak children compared to the CZ and HU needs
further exploration.
3.5. Behavioural factors
Use of plastic products in households is considered an im-
portant exposure source to phthalates and in EU countries it is
prohibited to market toys containing phthalates for children below
3 years of age. As all children in the DEMOCOPHES pilot study
were older, they might have been in contact with toys containing
phthalates. Nevertheless, playing with plastic toys was often re-
ported less signiﬁcantly for Slovak children than for children from
Hungary (Po0.001), which is in contradiction with the higher
concentrations of phthalate metabolites found in Slovak children.
3.6. Living area
It is known that phthalates are ubiquitous components of the
indoor environment (Wechsler and Nazaroff, 2008). PVC ﬂooring
was reported signiﬁcantly more in CZ (Po0.001) than in SK and
HU and urinary MBzP concentrations in both mothers and children
were signiﬁcantly related to the use of PVC ﬂooring (Den Hond
et al., unpublished data) but again this ﬁnding does not explain the
higher concentrations of phthalate metabolites in SK.
Time spent daily in cars, use of bottled water or public sources
and potentially contributing local industrial pollution cannot ex-
plain the observed differences for phthalate concentrations inPlease cite this article as: Černá, M., et al., Case study: Possible diffe
Slovak populations identiﬁed.... Environ. Res. (2014), http://dx.doi.orgchildren from SK that had (at least according to BQ) signiﬁcant
lower exposures to these potential sources than the other two
countries (Po0.05). Residence in urban or rural area did not show
up as a signiﬁcant exposure determinant (Po0.05).
3.7. Education
The education of the study subjects was skewed towards a
higher educational level expressed according to the International
Standard Classiﬁcation of Education (ISCED) categories. Whereas
mothers with a tertiary education prevail in CZ and SK, slightly
more mothers have secondary education in HU (P¼0.051) not
explaining the results observed for SK.
3.8. Correlation of urinary metabolite concentrations between mo-
thers and children
In all three countries, moderate correlations between mother's
and children's metabolite concentrations were observed while
interestingly the correlations between mother and child appeared
weaker in SK (Spearman correlation coefﬁcients for different me-
tabolites 0.13–0.34) than in CZ (0.21–0.56) and especially in HU
(0.35–0.57) indicating that maybe there is a speciﬁc though yet
unknown source of exposure for children in SK.
3.9. Health-related limit values
To put the results for the three countries in a more general
health risk context, the proportion of individuals with biomarker
levels above the existing health-based guidance values (Schulz
et al., 2012) was calculated. The only existing health-based gui-
dance values have been established by the German Human Bio-
monitoring Commission for the sum of two DEHP metabolites
(5OH-MEHPþ5OXO-MEHP): 300 mg/L of urine for women of re-
productive age and 500 mg/L of urine for children (Kasper-Son-
nenberg et al., 2012; Schulz et al., 2007, 2011). The concentrations
below these values are supposed not to be damaging to human
health. In our study, the value of 300 mg/L was exceeded in only
one (0.9%) of 115 evaluated Hungarian mothers out of 357 total
mothers included in all three countries. In children, the value of
500 mg/L was slightly exceeded only in one boy in each of the three
countries.4. Conclusion
The major objective of this paper was to explore whether sig-
niﬁcant differences in the urinary concentrations of phthalate
metabolites among the populations of the Czech Republic, Hun-
gary, and Slovakia exist.
To the best of our knowledge, the data on urinary phthalate
metabolites obtained in DEMOCOPHES study are the ﬁrst available
for the three countries under study.ren
/10.Concentrations of some phthalate metabolites (5OH-MEHP,
5OXO-MEHP and sum of both metabolites) are signiﬁcantly
higher in Slovak children compared with the two other
countries. The only factor that shows signiﬁcant differences and therefore
may explain the observations is the use of personal care
products.
The results do indicate the importance of further human bio-
monitoring studies of phthalate exposure concentrations to be
conducted in a sufﬁcient number of children with differentces in phthalates exposure among the Czech, Hungarian, and
1016/j.envres.2014.10.025i
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and possibly beyond.Acknowledgment
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